Eicosapentaenoic acid induces fas-mediated apoptosis through a p53-dependent pathway in hepatoma cells

Cancer Journal

Volumn 10, Issue 3, 2004, Pages 190-200

  Chi, Tian Yi ^a,b   Chen, George G ^a,b   Lai, Paul B S ^a,b  

^a Prince of Wales Hospital ^*

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Eicosapentaenoic acid; Fas; Hepatocellular carcinoma; p53

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; DNA FRAGMENT; DNA NUCLEOTIDYLEXOTRANSFERASE; FAS ANTIGEN; ICOSAPENTAENOIC ACID; MESSENGER RNA; PROTEIN P53; FAS LIGAND; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL DEATH; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA STRAND BREAKAGE; DOSE RESPONSE; DRUG EFFECT; HEPATOMA CELL; HUMAN; HUMAN CELL; MUTATION; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; GENETICS; IN VITRO STUDY; LIVER CELL CARCINOMA; PATHOPHYSIOLOGY; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; EICOSAPENTAENOIC ACID; FAS LIGAND PROTEIN; GENES, P53; HUMANS; MEMBRANE GLYCOPROTEINS;

EID: 4644310836     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200405000-00009     Document Type: Article

References (40)

1. Venook AP. Treatment of hepatocellular carcinoma: too many options? J Clin Oncol 1994;12:1323-1334.
2. Tanaka K, Nakamura S, Numata K et al. The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 1998;82:78-85.
3. Levin B, Amos C. Therapy of unresectable hepatocellular carcinoma. N Engl J Med 1995;332:1294-1296.
4. Sugioka A, Tsuzuki T, Kanai T. Postresection prognosis of patients with hepatocellular carcinoma. Surgery 1993;113:612-618.
5. Lai PB, Ross JA, Fearon KC et al. Cell cycle arrest and induction of apoptosis in pancreatic cancer cells exposed to eicosapentaenoic acid in vitro. Br J Cancer 1996;74:1375-1383.
6. Chiu LC, Wan JM. Induction of apoptosis in HL-60 cells by eicosapentaenoic acid (EPA) is associated with downregulation of bcl-2 expression. Cancer Lett 1999;145:17-27.
7. Colquhoun A, Schumacher RI. Gamma-linolenic acid and eicosapentaenoic acid induce modifications in mitochondrial metabolism, reactive oxygen species generation, lipid peroxidation and apoptosis in Walker 256 rat carcinosarcoma cells. Biochim Biophys Acta 2001;1533:207-219.
8. Latham P, Lund EK, Brown JC et al. Effects of cellular redox balance on induction of apoptosis by eicosapentaenoic acid in HT29 colorectal adenocarcinoma cells and rat colon in vivo. Gut 2001;49:97-105.
9. Heimli H, Giske C, Naderi S et al. Eicosapentaenoic acid promotes apoptosis in Ramos cells via activation of caspase-3 and -9. Lipids 2002;37:797-802.
10. Ait-Said F, Elalamy I, Werts C et al. Inhibition by eicosapentaenoic acid of IL-1beta-induced PGHS-2 expression in human microvascular endothelial cells: involvement of lipoxygenase-derived metabolites and p38 MAPK pathway. Biochim Biophys Acta 2003;1631:77-84.
11. Clarke RG, Lund EK, Latham P et al. Effect of eicosapentaenoic acid on the proliferation and incidence of apoptosis in the colorectal cell line HT29. Lipid 1999;34:1287-1295.
12. Cave WT Jr. Dietary n-3 (omega-3) polyunsaturated fatty acid effects on animal tumorigenesis. FASEB J 1991;5:2160-2166.
13. Murata M, Kaji H, Iida K et al. Dual action of eicosapentaenoic acid in hepatoma cells: up-regulation of metabolic action of insulin and inhibition of cell proliferation. J Biol Chem 2001;276:31422-31428.
14. Chen GG, Merchant JL, Lai PB et al. Mutation of p53 in recurrent hepatocellular carcinoma and its association with the expression of ZBP-89. Am J Pathol 2003;162:1823-1829.
15. Ito Y, Monden M, Takeda T et al. The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma. Br J Cancer 2000;82:1211-1217.
16. Lee SH, Shin MS, Lee HS et al. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma. Hum Pathol 2001;32:250-256.
17. McCormick F. Cancer therapy based on p53. Cancer J Sci Am 1999;5:139-144.
18. Micheau O, Solary E, Hammann A et al. Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity. J Natl Cancer Inst 1997;89:783-789.
19. Cappello F, Bellafiore M, Palma A et al. Defective apoptosis and tumorigenesis: role of p53 mutation and Fas/FasL system dysregulation. Eur J Histochem 2002;46:199-208.
20. Aden DP, Fogel A, Plotkin S et al. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 1979;228:615-616.
21. Ponchel F, Puisieux A, Tabone E et al. Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor beta 1-mediated apoptosis. Cancer Res 1994;54:2064-2068.
22. Nakabayashi H, Taketa K, Yamane T et al. Phenotypical stability of a human hepatoma cell line, Huh-7, in long-term culture with chemically defined medium. Gann 1984;75:151-158.
23. Hsu IC, Tokiwa T, Bennett W et al. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis 1993;14:987-992.
24. Tsai WS, Nagawa H, Muto T. Differential effects of polyunsaturated fatty acids on chemosensitivity of NIH3T3 cells and its transformants. Int J Cancer 1997;70:357-361.
25. Cazenave C, Stein CA, Loreau N et al. Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides. Nucleic Acids Res 1989;17:4255-4273.
26. Murakami A, Ohigashi H, Koshimizu K. Anti-tumor promotion with food phytochemicals: a strategy for cancer chemoprevention. Biosci Biotechnol Biochem 1996;60:1-8.
27. Anel J, Naval J, Desportes B et al. Increased cytotoxicity of polyunsaturated fatty acids on human tumoral B and T-cell lines compared with normal lymphocytes. Leukemia 1992;6:680-688.
28. Koskelo EK, Boswell K, Carl L et al. High levels of dietary arachidonic acid triglyceride exhibit no subchronic toxicity in rats. Lipids 1997;32:397-405.
29. Kokura S, Nakagawa T, Hara Y et al. Enhancement of lipid peroxidation and of the antitumor effect of hyperthermia upon combination with oral eicosapentaenoic acid. Cancer Lett 2002;185:139-144.
30. Hayashi H, Sugio K, Matsumata T et al. The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan. Hepatology 1995;22:1702-1707.
31. Jeng KS, Sheen IS, Chen BF et al. Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection? Arch Surg 2000;135:1329-1333.
32. Yun C, Lee JH, Park H et al. Chemotherapeutic drug, Adriamycin, restores the function of p53 protein in hepatitis B virus X (HBx) protein-expressing liver cells. Oncogene 2000;19:5163-5172.
33. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331.
34. Owen-Schaub LB, Zhang W, Cusack JC et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 1995;15:3032-3040.
35. Muller M, Wilder S, Bannasch D et al. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med 1998;188:2033-2045.
36. Li Y, Raffo AJ, Drew L et al. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143. Cancer Res 2003;63:1527-1533.
37. Zalcenstein A, Stambolsky P, Weisz L et al. Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants. Oncogene 2003;22:5667-5676.
38. Petak I, Tillman DM, Houghton JA. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines. Clin Cancer Res 2000;6:4432-4441.
39. Gutierrez del Arroyo A, Gil-Lamagniere C, Lazaro I et al. Involvement of p53 and interleukin 3 in the up-regulation of CD95 (APO-1/Fas) by X-ray irradiation. Oncogene 2000;19:3647-3655.
40. Heimli H, Finstad HS, Drevon CA. Necrosis and apoptosis in lymphoma cell lines exposed to eicosapentaenoic acid and antioxidants. Lipids 2001;36:613-621.